Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J.-P. Machiels(Cliniques Universitaires Saint-Luc), Vincent Grégoire(HEC Montréal)
Cited by 846
Related Papers
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
|Radiotherapy and Oncology|2017|374
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
|Annals of Oncology|2017|80
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
|Annals of Oncology|2016|45
Long-term update of the 24954 EORTC phase III trial on larynx preservation
|European Journal of Cancer|2016|45
Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study
|International Journal of Cancer|2024|42